Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yashiro Pharmaceutical, officially known as Yashiro Seiyaku Co., Ltd., is a Japanese pharmaceutical company specializing in the development, manufacture, and sale of medicinal products. Founded in 1948 and headquartered in Hyogo Prefecture, the company has established a strong reputation for producing external preparations such as ointments, creams, and eye drops, as well as internal medicines and quasi-drugs. Yashiro Pharmaceutical operates as both a manufacturer of its own brands and a contract development and manufacturing organization (CDMO), providing high-quality production services to other pharmaceutical firms. The company utilizes GMP-compliant facilities to ensure the safety and efficacy of its diverse product portfolio, which serves the Japanese domestic healthcare market. Its business model focuses on providing reliable generic and over-the-counter (OTC) solutions for common health conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yashiro Pharmaceutical.